— Know what they know.
Not Investment Advice
Also trades as: ANN.AX (ASX) · $vol 15M · ANSLY (OTC) · $vol 0M

ANSLF OTC

Ansell Limited
1W: +0.0% 1M: +1.9% 3M: +10.5% YTD: +2.8% 1Y: +8.1% 3Y: +60.6% 5Y: -19.5%
$21.64
+0.00 (+0.00%)
 
OTC · Healthcare · Medical - Instruments & Supplies · Tech Score Buy · Power 54 · $3.0B mcap · 142M float · 0.0000% daily turnover · Short 100% of daily vol

Income Trends

Revenue
$2.2B +9.1% ▲
5Y CAGR: +1.4%
Gross Profit
$905M +9.7% ▲
5Y CAGR: +2.3%
Operating Income
$343M +214.3% ▲
5Y CAGR: -0.1%
Net Income
$213M +109.6% ▲
5Y CAGR: -2.9%
EPS (Diluted)
$1.48 +108.5% ▲
5Y CAGR: -5.0%
EBITDA
$343M +31.8% ▲
5Y CAGR: -2.9%

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2022FY2023FY2024FY2025FY2026
Revenue$1.9B$1.6B$1.6B$2.0B$2.2B
YoY Growth-9.3%-11.7%-0.9%+23.7%+9.1%
Cost of Revenue$1.2B$1.0B$1.0B$1.2B$1.3B
Gross Profit$625M$604M$625M$825M$905M
Gross Margin33.8%37.0%38.6%41.2%41.4%
R&D Expenses$17M$18M$0$21M$0
SG&A Expenses$412M$409M$496M$641M$540M
Operating Expenses$392M$407M$496M$716M$562M
Operating Income$237M$210M$129M$109M$343M
Operating Margin12.8%12.9%8.0%5.4%15.7%
Interest Expense$19M$21M$25M$47M$46M
Income Before Tax$206M$189M$109M$144M$285M
Tax Expense$46M$39M$31M$40M$71M
Net Income$159M$148M$76M$102M$213M
Net Margin8.6%9.1%4.7%5.1%9.7%
EPS (Diluted)$1.18$1.15$0.59$0.71$1.48
EBITDA$289M$275M$202M$260M$343M
Shares Outstanding128M127M129M146M144M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms